amifostine anhydrous has been researched along with Neoplasms, Pleural in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zellos, L | 1 |
| Richards, WG | 1 |
| Capalbo, L | 1 |
| Jaklitsch, MT | 1 |
| Chirieac, LR | 1 |
| Johnson, BE | 1 |
| Bueno, R | 1 |
| Sugarbaker, DJ | 1 |
1 trial available for amifostine anhydrous and Neoplasms, Pleural
| Article | Year |
|---|---|
A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma.
Topics: Amifostine; Antineoplastic Agents; Cisplatin; Cytoprotection; Feasibility Studies; Female; Humans; H | 2009 |